Governing Agentic AI in Clinical Trials with watsonx.governance¶

Description¶

IBM's watsonx.governance plays a crucial role in governing clinical drug trial use cases, particularly when employing Agentic AI. This system helps manage risks and ensure compliance with regulations like HIPAA and the EU AI Act.

Agentic AI introduces new risks, including: - Human manipulation - Cascading hallucinations - Difficulty in maintaining traceability and accountability

watsonx.governance offers a platform to identify, document, and mitigate these risks throughout the life cycle of agents and tools. It measures essential metrics like: - Faithfulness - Context relevance

These measurements help ensure that generated responses adhere to company guidelines and ethical standards.

🎥 Watch the Demo¶

👉 Click on this link to watch the complete demo